Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for BNBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -0.9829M
March 31, 2026 -2.050M
December 31, 2025 -5.545M
September 30, 2025 -3.377M
June 30, 2025 -2.631M
March 31, 2025 -3.269M
December 31, 2024 -3.309M
September 30, 2024 -3.388M
June 30, 2024 -3.356M
March 31, 2024 -3.21M
December 31, 2023 -3.758M
September 30, 2023 -2.680M
June 30, 2023 -1.369M
March 31, 2023 0.2144M
December 31, 2022 -2.383M
September 30, 2022 -3.259M
June 30, 2022 -1.754M
March 31, 2022 -0.2619M
December 31, 2021 -3.702M
September 30, 2021 -4.712M
June 30, 2021 -1.250M
March 31, 2021 -3.270M
December 31, 2020 -4.156M
September 30, 2020 -2.983M
June 30, 2020 -3.009M
Date Value
March 31, 2020 -2.420M
December 31, 2019 -2.731M
September 30, 2019 -1.777M
June 30, 2019 -1.283M
March 31, 2019 -2.288M
December 31, 2018 -1.514M
September 30, 2018 -2.509M
June 30, 2018 -1.129M
March 31, 2018 -0.707M
December 31, 2017 -2.573M
September 30, 2017 -0.9139M
June 30, 2017 -1.866M
March 31, 2017 -2.630M
December 31, 2016 -2.069M
September 30, 2016 -2.446M
June 30, 2016 -2.227M
March 31, 2016 -2.503M
December 31, 2015 -2.721M
September 30, 2015 -1.739M
June 30, 2015 -1.255M
March 31, 2015 -1.616M
December 31, 2014 -2.356M
September 30, 2014 -2.242M
June 30, 2014 -2.008M
March 31, 2014 -2.196M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.055M
HealthEquity, Inc. 136.16M
SCWorx Corp. -0.0057M
Health Catalyst, Inc. 0.275M
Diaceutics Plc --